NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Septerna, Inc ...
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
New research suggests restoring stellate cells to their healthy and protective state could simultaneously reduce liver scarring and improve liver function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback